F. Spirito

发表

Peginterferon alfa-2b and ribavirin for 12 vs. 24 weeks in HCV genotype 2 or 3.

A. Andriulli, A. Mangia, M. Persico, 2005, The New England journal of medicine.

Individualized treatment duration for hepatitis C genotype 1 patients: A randomized controlled trial

A. Andriulli, A. Mangia, L. Mottola, 2007, Hepatology.

Endoscopic stenting for colorectal cancer obstruction as a bridge‐to‐surgery strategy

A. Andriulli, A. Di Leo, G. Losurdo, 2020, European journal of clinical investigation.

High doses of interferon in combination with ribavirin are more effective than the standard regimen in patients with HCV genotype 1 chronic hepatitis.

A. Andriulli, A. Mangia, G. Leandro, 2002, Journal of hepatology.

Estimates of HCV-1 Patients Attaining RVR Following Dual Therapy with Peg-Interferon and Ribavirin

A. Andriulli, M. Valvano, G. Niro, 2013, Digestive Diseases and Sciences.

Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis.

A. Andriulli, A. Mangia, G. Gambassi, 2000, Gastrointestinal endoscopy.

Granular cell tumor of the esophagus.

M. Bisceglia, D. Facciorusso, A. Giacobbe, 1988, The American journal of gastroenterology.

A randomized controlled trial of pegylated interferon α‐2a (40 KD) or interferon α‐2a plus ribavirin and amantadine vs interferon α‐2a and ribavirin in treatment‐naïve patients with chronic hepatitis C

A. Andriulli, V. Pazienza, A. Mangia, 2005, Journal of viral hepatitis.

HCV genotypes in patients with liver disease of different stages and severity.

A. Andriulli, A. Mangia, M. Rizzetto, 1997, Journal of hepatology.

Incidence Rates of Post-ERCP Complications: A Systematic Survey of Prospective Studies

Angelo Andriulli, Alberto Pilotto, A. Andriulli, 2007, The American Journal of Gastroenterology.

Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate.

A. Andriulli, F. Perri, E. Ciliberto, 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Antisecretory vs. antiproteasic drugs in the prevention of post-ERCP pancreatitis: the evidence-based medicine derived from a meta-analysis study.

A. Andriulli, G. Leandro, M. Quitadamo, 2003, JOP : Journal of the pancreas.

Closure of a gastrocutaneous fistula by a tulip-bundle technique.

A. Andriulli, F. Perri, D. Scimeca, 2011, Endoscopy.

Prolonged treatment (2 years) with different doses (3 versus 6 MU) of interferon alpha-2b for chronic hepatitis type C. Results of a multicenter randomized trial.

A. Andriulli, A. Mangia, M. Rizzetto, 1997, Journal of hepatology.